-
Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore
07 Jun 2024 01:15 GMT
… products. Three-fourths of its sales come from the women’s … hit `2,000 crore in sales in FY25.
Also read: Resilience … pharma sector has largely been led by PE funds.
However, homegrown drugmakers … a pharma company that evaluated it in the past.
“The sales and …
-
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
06 Jun 2024 21:30 GMT
… for nearly $60.
Finally, many drugmakers get acquired by their larger … that the drug will generate sales of $364.6 million … Meanwhile, analysts expect Leqembi’s sales to surge to $2.17 … while the website gives the pharma an Accumulation/Distribution rating …
-
Mankind Pharma scouts for M&A deals to boost local branded biz
06 Jun 2024 18:41 GMT
… Juneja said, The homegrown drugmaker in the past acquired the … the valuation expectations in the pharma sector are unrealistic.
… local companies pan-India sales network.
Juneja said they … which means realigning the sales strategy to focus on specialists …
-
Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle Pharma
06 Jun 2024 14:56 GMT
… recent months, Vanda Pharmaceuticals has been busy … England-based rare disease drugmaker Cycle Pharmaceuticals revealed an $8- … establish a "specialty sales force, a prescriber awareness … rollout.
As for Cycle Pharmaceuticals, the company markets six …
-
STAT+: Pharmalittle: We’re reading about the aftermath of FDA vote on MDMA, rising pharma layoffs, and more
06 Jun 2024 13:17 GMT
… gray skies hovering over the Pharmalot campus again. We are doing … the promising Chinese market where drugmakers are developing at least 15 … citing clinical trial records. The drugmaker hopes that demand for its … 2021 and Novo Nordisk saw sales of the drug in …
-
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists
06 Jun 2024 11:20 GMT
… SHANGHAI (Reuters) - Employees of drugmaker WuXi AppTec, under U.S … company, which reported U.S. sales of about $3.6 billion … 's Journal of Pharmaceutical Practice and Service that it … trained "military pharmacy" researchers under a plan …
-
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
05 Jun 2024 01:32 GMT
… ;s Jim Cramer why the drugmaker believes it can almost double … .8 billion in 2023. The pharmaceutical giant also plans to release … 's first quarter saw sales increase 19% and its oncology …
-
Drugmakers Seek New Therapeutic Indications to Extend Product Life Cycles
04 Jun 2024 10:43 GMT
… . 4 (Korea Bizwire) – Pharmaceutical and biotechnology companies at home … disease, and the American drugmaker Eli Lilly is also … diverse therapeutic effects.
Domestic pharmaceutical firms are accelerating efforts … do not immediately increase sales due to the …
-
Weekly market recap: Record moment resumes as tech stocks lead the way
07 Jun 2024 07:01 GMT
… sector level, technology, and pharmaceutical stocks shone, leading the broad … on Thursday on news that sales of Wegovy more than … trading days. This lifted Zealand Pharma’s shares, which jumped … court ruling that the British drugmaker must face trials over …
-
Amgen preps Uplizna filing for a second indication
06 Jun 2024 12:38 GMT
Amgen has moved closer to a second indication for its B cell-depleting therapy Uplizna, acquired as part of its $27.8 billion takeover of Horizon Therapeutics last year, after positive results in a phase 3 trial.
The drugmaker said that based on the …